abstract |
[PROBLEMS] To treat protein kinase-mediated diseases such as cancer, autoimmune diseases, inflammatory diseases, bone diseases, metabolic diseases, neurological and neurodegenerative diseases, cardiovascular diseases, allergies and asthma, Alzheimer's disease and hormone-related diseases. Providing medicine for A 5-cyano-4 (pyrrolo [2,3B] pyridin-3-yl) -pyrimidine derivative represented by formula I-1 and a pharmaceutically acceptable composition containing the compound. [Effect] The compound and its pharmaceutically acceptable composition are useful as an inhibitor of PLK protein kinase, and are useful for the treatment or prevention of the diseases listed as problems. [Selection figure] None |